QLY Biotech Group Corp. [Rocket]

In millions, except per share items	Feb-28-23	Nov-30-22	Aug-31-22	May-31-22	Feb-28-22	Nov-30-21	Aug-31-21	May-31-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Revenue growth	-100.0%	-100.0%	-100.0%			0.0%	0.0%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross margin				65.0%	65.0%	65.0%	65.0%
Selling, general and administrative [+]	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
General and administrative	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other operating expenses							0.0
EBITDA [+]			0.0	0.0			0.0	0.0
EBITDA growth	471.1%	-25.7%	-52.1%	-84.2%	-87.7%	47.6%	164.2%
EBITDA margin				-168.3%	-130.4%	-670.1%	-781.1%
Depreciation			0.0	0.0			0.0	0.0
EBITA	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EBITA margin				-166.9%	-129.0%	-669.4%	-781.1%
Amortization of intangibles			0.0	0.0			0.0	0.0
EBIT [+]	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EBIT growth	563.6%	-27.7%	-54.8%	-86.8%	-90.1%	32.7%	135.6%
EBIT margin				-146.9%	-109.0%	-659.4%	-781.1%
Other income (expense), net							0.0
Pre-tax income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net margin				-216.9%	-179.0%	-729.4%	-737.6%

Basic EPS [+]	($0.01)	$0.00	$0.00	$0.00	$0.00	($0.01)	($0.01)	($0.01)
Growth	304.1%	-34.6%	-52.2%	-74.3%	-80.0%	227.8%	328.0%
Diluted EPS [+]	($0.01)	$0.00	$0.00	$0.00	$0.00	($0.01)	($0.01)	($0.01)
Growth	304.1%	-34.6%	-52.2%	-74.3%	-80.0%	227.8%	328.0%

Shares outstanding (basic) [+]	3.9	3.9	3.9	3.9	3.9	3.9	3.9	3.7
Growth	0.0%	0.0%	0.0%	5.7%	12.6%	20.3%	29.3%
Shares outstanding (diluted) [+]	3.9	3.9	3.9	3.9	3.9	3.9	3.9	3.7
Growth	0.0%	0.0%	0.0%	5.7%	12.6%	20.3%	29.3%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.